Showing results (131-140 of 160) with videos related to
Sort By:
Pageof 16
Biochemistry|November 5, 1999
Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxinM W Pennington, M D Lanigan, K Kalman, et al.Scientific Reports|March 29, 2014
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseasesM Harunur Rashid, Redwan Huq, Mark R Tanner, et al.The Journal of Biological Chemistry|December 8, 2009
Potassium channel modulation by a toxin domain in matrix metalloprotease 23Srikant Rangaraju, Keith K Khoo, Zhi-Ping Feng, et al.Expert Reviews in Molecular Medicine|October 3, 2022
Precision oncology using ex vivo technology: a step towards individualised cancer care?Sophie T Williams, Greg Wells, Samantha Conroy, et al.Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Rational design and synthesis of selective BACE-1 inhibitorsStephen F Brady, Satendra Singh, Ming Chih Crouthamel, et al.British Journal of Pharmacology|February 8, 2021
K<sub>V</sub> 1.3 channels are novel determinants of macrophage-dependent endothelial dysfunction in angiotensin II-induced hypertension in miceMiguel A Olivencia, Marta Martínez-Casales, Diego A Peraza, et al.The Journal of Biological Chemistry|December 25, 2019
Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa<sub>v</sub>1.7Robert A Neff, Mack Flinspach, Alan Gibbs, et al.Inorganic Chemistry|August 7, 2001
Structural and oxo-transfer reactivity differences of hexacoordinate and pentacoordinate (nitro)(tetraphenylporphinato)cobalt(III) derivativesJ Goodwin, R Bailey, W Pennington, et al.Journal of Neuroinflammation|June 28, 2017
A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activationSrikant Rangaraju, Syed Ali Raza, Andrea Pennati, et al.Toxicon : Official Journal of the International Society on Toxinology|August 27, 2011
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseasesVictor Chi, Michael W Pennington, Raymond S Norton, et al.Pageof 16